Litigation
Halozyme, Inc. v. Merck Sharp and Dohme LLC
pending2:25-cv-03179
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2025-04-24
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Halozyme filed a patent infringement and declaratory judgment action against Merck in the District of New Jersey. The '692 patent is one of 15 patents-in-suit asserted against Merck's subcutaneous Keytruda, appearing as Count 10. The case remains pending, with the complaint and Merck's answer as the primary substantive filings.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).